DrugBiological
Interferon beta clinical trials
Also written Interferon-beta.
- studies test it
- 9
- open now
- 1
- in phase 3
- 5
- first study started
- 1999
Keep track of what changes. Save the interferon beta studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
Other names
Combined with it in one product
Studies by the year they started
9 studies that test it; most in 2017 (2)
| Year | Studies |
|---|---|
| 1999 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2017 | 2 |
| 2020 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 3
- Phase 3
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 6
Tanabe Pharma Corporation (1) · Population Health Research Institute (1) · Case Comprehensive Cancer Center (1) · Faron Pharmaceuticals Ltd (1) · Heidelberg University (1) · University of Turin, Italy (1) · Fundació Institut Germans Trias i Pujol (1) · Genzyme, a Sanofi Company (1)
Often tested with
Tested in the same studies.
Telaprevir (1) · Ribavirin (1) · Interferon beta-1b (1) · Interferon beta-1a (1) · Colchicine (1) · Aspirin (1) · Rivaroxaban (1) · Alemtuzumab (1)
Studies
Open first, then newest update. How each study uses interferon beta is read from its arms, and is right about nine times in ten.
Testing it · 9
- Tolerogenic Dendritic Cells as a Therapeutic Strategy for the Treatment of Multiple Sclerosis Patients (TOLERVIT-MS)RecruitingPhase 1Fundació Institut Germans Trias i PujolNCT02903537Written as Interferon-beta
- A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab in Pediatric Patients With RRMS With Disease Activity on Prior DMTTerminatedPhase 3Genzyme, a Sanofi CompanyNCT03368664Written as Beta-Interferon
- Efficacy and Safety of MP-424, Interferon Beta (IFN Beta), and Ribavirin(RBV) in Treatment-Naïve or Having Received Interferon Based Therapy With Chronic Hepatitis C (CHC)CompletedPhase 3Tanabe Pharma CorporationNCT01753570Written as IFN beta(24 weeks)
- Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) TrialCompletedPhase 3Population Health Research InstituteNCT04324463Written as Interferon-Beta
- Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell CarcinomaTerminatedPhase 1/2Fred Hutchinson Cancer CenterNCT01758458Written as Recombinant Interferon Beta
- Interferon Beta in Treating Patients With Metastatic Cutaneous Melanoma or Ocular MelanomaCompletedPhase 2Case Comprehensive Cancer CenterNCT00085306Written as recombinant interferon beta
- Safety, Tolerability and Preliminary Efficacy of FP-1201 in ALI and ARDS. Phase I/IICompletedPhase 1/2Faron Pharmaceuticals LtdNCT00789685Written as Interferon Beta
- Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate UveitisCompletedPhase 3Heidelberg UniversityNCT00344253Written as Interferon beta
- Optimizing IFN Beta - 1B DoseCompletedPhase 3University of Turin, ItalyNCT00473213Written as Interferon Beta 1
Given in every arm · 4 — interferon beta is usual care beside what is tested
- Study to Evaluate Oral BIIB061 Added to Interferon-beta1 (IFN-β1) or Glatiramer Acetate in Relapsing Multiple Sclerosis (RMS)WithdrawnPhase 2BiogenNCT04079088Written as Interferon-beta1
- Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell CarcinomaTerminatedPhase 1/2Fred Hutchinson Cancer CenterNCT02584829Written as Recombinant Interferon Beta
- A Phase 2 Study of Cladribine Add-on to Interferon-beta (IFN-beta) Therapy in Multiple Sclerosis (MS) Subjects With Active Disease (ONWARD)CompletedPhase 2EMD Serono Research & Development Institute, Inc.NCT00436826Written as Interferon-beta (IFN-beta)
- Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-betaTerminatedPhase 3SanofiNCT01252355Written as Interferon-beta (IFN-beta)
As the comparator · 1 — what is tested is compared with interferon beta
Codes
What other systems call interferon beta · ClinicalTrials.gg INT008552
- MeSH (NLM) D016899Interferon-betaOne source ClinicalTrials.gov
- UNII (FDA) V9GU1EM8SFINTERFERON BETAOne source FDA
- RxNorm 4381One source FDA
- NCI Thesaurus C495Recombinant Interferon BetaOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D016899 | Interferon-beta | One source ClinicalTrials.gov |
| UNII (FDA) | V9GU1EM8SF | INTERFERON BETA | One source FDA |
| RxNorm | 4381 | — | One source FDA |
| NCI Thesaurus | C495 | Recombinant Interferon Beta | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.